Look for:

CSL LTD.


ISIN:
AU000000CSL8
WKN:
CSL

2023/09/28 08:03:43
Price
152.60 EUR
Difference 0.00% (0.00)

General attributes

ISINAU000000CSL8
SymbolCSL
ExchangeMunich
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)73,556 EUR
BenchmarkASX ALL ORDINARIES INDEX

Market data

Bid (Bid size)152.10 EUR (40)
Ask (Ask size)153.30 EUR (40)
Open152.60 EUR
High152.60 EUR
Low152.60 EUR
Close (prev. day)152.60 EUR
VWAP160.15 EUR
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Futures and Options

Related Futures-
Related Options1,561

PDF Downloads

Annual report: CSL LTD.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research

Date Headline Download
2023/09/22 de Equity Weekly PDF Download
2023/09/18 de Aktienempfehlungen Österreich PDF Download
2023/09/18 de Equity Weekly PDF Download
2023/09/11 de Aktienempfehlungen Österreich PDF Download
2023/09/08 de Equity Weekly PDF Download


2023/09/28 08:03:43
Price
152.60 EUR
Difference 0.00% (0.00)

General attributes

ISINAU000000CSL8
SymbolCSL
ExchangeMunich
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)73,556 EUR
BenchmarkASX ALL ORDINARIES INDEX

Market data

Bid (Bid size)152.10 EUR (40)
Ask (Ask size)153.30 EUR (40)
Open152.60 EUR
High152.60 EUR
Low152.60 EUR
Close (prev. day)152.60 EUR
VWAP160.15 EUR
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Performance and Risk

6M1Y3Y
Perf (%)-14.70%-20.27%-14.84%
Perf (abs.)-26.30-38.80-26.60
Beta0.410.580.71
Volatility17.9417.5818.93
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)153.52 EUR (0)
Ø price 30 days | Ø volume 30 days (pcs.)158.59 EUR (3)
Ø price 100 days | Ø volume 100 days (pcs.)168.66 EUR (10)
Ø price 250 days | Ø volume 250 days (pcs.)178.81 EUR (5)
YTD High | date201.60 EUR (2023/02/03)
YTD Low | date152.60 EUR (2023/09/27)
52 Weeks High | date201.60 EUR (2023/02/03)
52 Weeks Low | date152.60 EUR (2023/09/27)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2023/09/2811:05151.75 EUR0.002
Stuttgart2023/09/2808:05152.00 EUR0.001
Munich2023/09/2808:03152.60 EUR0.001
Hamburg2023/09/2808:00151.65 EUR0.001
Frankfurt2023/09/2809:26151.40 EUR0.001
FINRA other OTC Issues2023/09/2716:41157.79 USD0.113
Duesseldorf2023/09/2809:30151.50 EUR0.002
Berlin2023/09/2811:22152.25 EUR0.003
BX Swiss2023/09/1418:00152.868 CHF0.011
Australian Securities Exchange2023/09/2808:10252.04 AUD143.8722,540

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=30673&ID_TYPE_IMAGE_LOGO=2

Contact Details

CSL LTD.
- -
655 Elizabeth Street - 3000 Melbourne
Telefon: +61-3-9389-1911
Fax: +61-3-9389-1434
E-mail: media@csl.com.au

PDF Downloads

Annual report: CSL LTD.PDF Download

Company Profile

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.

Members of Management Board

Paul PerreaultChairman of Managing Board
Alan WillsMember of Executive Committee
Bill CampbellMember of Executive Committee
Bill MezzanotteMember of Executive Committee
Elizabeth WalkerMember of Executive Committee
Greg BossMember of Executive Committee
John LevyMember of Executive Committee
Mark HillMember of Executive Committee
Paul McKenzieMember of Executive Committee

Board of directors

Brian McNameeChairman of Supervisory Board
Andrew CuthbertsonMember of Supervisory Board
Duncan MaskellMember of Supervisory Board
Megan ClarkMember of Supervisory Board
Alison WatkinsMember of Supervisory Board
Bruce BrookMember of Supervisory Board
Carolyn HewsonMember of Supervisory Board
Marie McDonaldMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.